Key result
Cefepime-induced neurotoxicity can present with mutism, generalized rigidity, hyperreflexia, and myoclonus, mimicking neuroleptic malignant syndrome and serotonin syndrome, but resolves upon discontinuation.
Why the study?
Cefepime is a commonly used antibiotic, but cefepime-induced neurotoxicity is less commonly recognized and shares overlapping clinical features with serotonin syndrome, neuroleptic malignant syndrome, and catatonia.
Case Report (n=1)
No
Cefepime-induced neurotoxicity can mimic serotonin syndrome and neuroleptic malignant syndrome, and should be considered in patients with altered mental status and renal impairment.
Answers are grounded in this paper and cite their sources.
CIN may mimic serotonin syndrome in renally impaired patients on psychotropics; leaves open differentiation criteria beyond case reports.
Cefepime is a commonly used antibiotic. However, cefepime-induced neurotoxicity (CIN) is less commonly recognized. We describe a 75-year-old female on sertraline and risperidone who has been on cefepime for 28 days for treatment of osteomyelitis and presented with mutism, generalized rigidity, hyperreflexia, generalized stimulus-induced myoclonus, and reactive dilated pupils and found to have developed acute kidney injury. Although the diagnosis of serotonin syndrome (SS) and neuroleptic malignant syndrome (NMS) was suggested initially, the clinical picture was more compatible with CIN. Hemodialysis was suggested but gradual improvement in renal function allowed for gradual neurological recovery. This case highlights the importance of considering CIN in those who have been on Cefepime and present with altered mental status, especially in the appropriate clinical context and presence of risk factors. The overlap in clinical presentation between CIN, SS, NMS, and Catalonia may lead to a diagnostic challenge. Myoclonus seems to be characteristic of CIN and serves as a good clue to hint toward the diagnosis. This case helps to display the similarities and differences in the clinical presentation of these entities and therefore helps avoid confusion and prevents unnecessary therapeutic interventions.
No takes yet. Share an insight, caveat, or question.
Abu-Abaa et al. (2023) conducted a case report in Cefepime-induced neurotoxicity (n=1). Cefepime was evaluated on Neurological recovery. Cefepime-induced neurotoxicity can present with mutism, generalized rigidity, hyperreflexia, and myoclonus, mimicking neuroleptic malignant syndrome and serotonin syndrome, but resolves upon discontinuation.
Synapse has enriched 10 related papers. Consider them for comparative context: